Hemostasis Products Market to Reach USD 4.5 Billion by 2034, Driven by a 5.7% CAGR | States Transparency Market Research, Inc.

With the growing number of accidental cases, the number of surgeries required is proliferating. Due to this rising number, the demand for hemostasis products is expected to increase, which will likely drive the global landscape. The rising number of chronic diseases is expected to fuel the demand for surgical interventions. With the growing number of accidental cases, the number of surgeries required is proliferating. Due to this rising number, the demand for hemostasis products is expected to...
Comunicato Precedente

next
Comunicato Successivo

next
WILMINGTON, Del., (informazione.it - comunicati stampa - salute e benessere)

With the growing number of accidental cases, the number of surgeries required is proliferating. Due to this rising number, the demand for hemostasis products is expected to increase, which will likely drive the global landscape. The rising number of chronic diseases is expected to fuel the demand for surgical interventions.

This will fuel the demand for hemostasis products to reduce blood loss during surgeries. Orthopedic disorders are expected to drive the momentum toward the global hemostasis products realm. With the rising demand in new and emerging sectors, such products will cover a wider spectrum, creating prospects for key players.

The elevation of safety features and rising precision in drug delivery systems will likely augment products in the industry. The growing field of biotechnology will also help the proliferation of the products portfolio, driving the demand for the sector. The growing research and development activities in the competitive landscape will help leading manufacturers augment products. Innovations will elevate the overall efficiency of drug delivery, increasing the demand for products.

Request for sample PDF copy of report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=13880

Hemostasis is the body's natural response to an injury that results in bleeding. This response halts the bleeding and enables the body to begin healing the wound. It is a multi-step process that causes a bleeding artery to form a plug that seals off the damaged area and stops the blood flow.  In order to achieve hemostasis, different types of inorganic materials, metal-containing compounds, synthetic polymers, and natural polymers are used. Examples of natural polymers used in the medical industry for hemostasis include chitosan, cellulose, hyaluronic acid, alginate, collagen, and fibrin.

Further, materials such as peptides, polyurethane, polyvinyl alcohol, polyethylene glycol are used to manufacture synthetic hemostatic materials. It is interesting to note that the type of hemostatic material to be used is strongly dependent on its mechanism of action. For instance, hemostatic materials in the form of hydrogels encourage clotting through thickening the blood and raising the concentration of platelets and clotting factors. These substances absorb water and then swell, creating a local compression effect.

An astounding 310 million major surgical procedures are carried out annually across the globe, with 20 million occurring in Europe and 40–50 million in the U.S. Estimations suggest that 1-4% of these patients encounter mortality, while 15-25% experience significant postoperative morbidity. Additionally, 15-25% of these patients are readmitted within 30 days of the procedure. At 15% of all trauma deaths, post-traumatic hemorrhage ranks as the second most common cause of trauma-related mortality in humans. The rising number of surgical procedures worldwide, coupled with the expanding geriatric population of the globe is poised to bolster the hemostasis products market. The recent years has witnessed the advent of a number of external hemostasis products, examples of which include QuikClot powder, advanced coagulation sponge, and combat gauze. These hemostats are developed based on materials such as kaolin and zeolite, chitosan, gelatin, alginate, collagen, and others and are known to function by promoting hemostasis through physical compression or by triggering the coagulation cascade. In this context, in November 2023, Ethicon announced that it received the CE mark for ETHIZIATM, an adjunctive hemostat solution, clinically validated to achieve sustained hemostasis in case of severe bleeding complications.

Unlock Growth Potential in Your Industry! Download PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=13880

Technological development is another crucial factor that governs the growth of the ecosystem. As mentioned before, the development of biotechnology will aid elevated features for drug delivery systems. This factor will drive the demand for hemostasis products. Government initiatives to bolster the healthcare infrastructure will benefit key players. More prospects will be generated in the industry, which can be used to expand in the industry, benefiting the market.

Key Findings from the Market Report

Regional Profile

Hemostasis Products Market Report Scope:

Competitive Landscape

With several organizations cluttering the competitive landscape, innovation is a key mode of expansion adopted in the industry.

Key Developments in the Hemostasis Products Market

Hemostasis Products Market to Reach USD 4.5 Billion by 2034, Driven by a 5.7% CAGR | States Transparency Market Research, Inc.

Key Players

Market Segmentation

Products

Application

End User

Region

Buy this Premium Research Report:
https://www.transparencymarketresearch.com/checkout.php?rep_id=13880&ltype=S

More Trending Reports by Transparency Market Research –

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com   
Email: [email protected]
Follow Us: LinkedIn | Twitter | Blog | YouTube

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/hemostasis-products-market-to-reach-usd-4-5-billion-by-2034--driven-by-a-5-7-cagr--states-transparency-market-research-inc-302199255.html

Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Slide ShowSlide Show
Non disponibili